These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34024177)

  • 21. Technetium-99m methoxyisobutylisonitrile imaging in the follow-up of differentiated thyroid carcinoma.
    Sriprapaporn J; Toopmongkol C; Satayaban B; Chantamoon N
    Ann Acad Med Singap; 2002 Mar; 31(2):195-8. PubMed ID: 11957557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation of technetium-99m pertechnetate in a patient with metastases of thyroid carcinoma.
    Yamamoto Y; Nishiyama Y; Ono Y; Satoh K; Ohkawa M; Kawasaki Y; Tanabe M
    Ann Nucl Med; 1999 Oct; 13(5):357-9. PubMed ID: 10582808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.
    Rubello D; Mazzarotto R; Casara D
    Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma.
    Long B; Li L; Yao L; Chen S; Yi H; Ye X; Xu D; Wu P
    J Cancer Res Ther; 2015 Nov; 11 Suppl():C244-7. PubMed ID: 26612446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
    J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of (99m)Tc-pertechnetate whole body scan with neck and chest SPECT/CT for detection of post-surgical thyroid remnant and metastasis in differentiated thyroid cancer patients.
    Chantadisai M; Kingpetch K
    Ann Nucl Med; 2014 Aug; 28(7):674-82. PubMed ID: 24889127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of technetium scintigraphy and iodine uptake measurement during follow-up of differentiated thyroid cancer.
    Caglar M; Tuncel M; Alpar R
    Ann Nucl Med; 2004 Sep; 18(6):479-82. PubMed ID: 15515746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accumulation of iodine-131 and technetium-99m pertechnetate in thyroid carcinoma.
    Katagiri M; Suzuki S; Sadahiro S; Kubouchi K; Ohmura T; Tsumura O; Akatsuka S
    Clin Nucl Med; 1988 Apr; 13(4):276-9. PubMed ID: 2836118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
    Lind P; Igerc I; Kohlfürst S
    Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular retention of Tc-99m pertechnetate and Tc-99m sestamibi, mimicking thyroid carcinoma metastases.
    Tuncel M; Ozgen Kiratli P
    Rev Esp Med Nucl; 2007; 26(4):226-9. PubMed ID: 17662189
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical Value of
    Gao R; Zhang GJ; Wang YB; Liu Y; Wang F; Jia X; Liang YQ; Yang AM
    Sci Rep; 2018 Jan; 8(1):473. PubMed ID: 29323252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of (99m)Tc-pertechnetate thyroid scintigraphy in radioiodine therapy in a cohort of Chinese Graves' disease patients: a pilot clinical study.
    Hou H; Hu S; Fan R; Sun W; Zhang X; Tian M
    Biomed Res Int; 2015; 2015():974689. PubMed ID: 25879041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact factors for the outcome of the first
    Shangguan L; Fang S; Zhang P; Han S; Shen X; Geng Y; Luo D; Zhao C
    Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 99mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer.
    Rubello D; Salvatori M; Casara D; Piotto A; Toniato A; Gross MD; Al-Nahhas A; Muzzio PC; Pelizzo MR
    Eur J Surg Oncol; 2007 Sep; 33(7):902-6. PubMed ID: 17267163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of FDG-PET and technetium-99m MIBI SPECT to detect metastatic cervical lymph nodes in well-differentiated thyroid carcinoma with elevated serum HTG but negative I-131 whole body scan.
    Wu HS; Huang WS; Liu YC; Yen RF; Shen YY; Kao CH
    Anticancer Res; 2003; 23(5b):4235-8. PubMed ID: 14666632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unexpected radioactive iodine accumulation on whole-body scan after I-131 ablation therapy for differentiated thyroid cancer.
    Iwano S; Ito S; Kamiya S; Ito R; Kato K; Naganawa S
    Nagoya J Med Sci; 2020 May; 82(2):205-215. PubMed ID: 32581401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of technetium-99m pertechnetate in postoperative thyroid carcinoma. A comparative study with iodine-131.
    Khammash NF; Halkar RK; Abdel-Dayem HM
    Clin Nucl Med; 1988 Jan; 13(1):17-22. PubMed ID: 2832116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of normal reference values for thyroid uptake of technetium-99m pertechnetate in a Saudi population.
    Alshahrani A; Syed GM; Khan AH; Numani SP; Alnaim A; Alanazi F; Mahzari MM
    Ann Saudi Med; 2021; 41(2):86-90. PubMed ID: 33818150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of the success of thyroid remnant ablation using preablative 99mTc pertechnetate scintigraphy and postablative dual 131I scintigraphy.
    Jung JS; Lee SM; Kim SJ; Choi J; Han SW
    Nucl Med Commun; 2015 Jan; 36(1):38-44. PubMed ID: 25299469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.